Occult Hepatitis B Virus Infection in Patients with Hepatocellular Carcinoma: Innocent Bystander, Cofactor, or Culprit?

Gastroenterology

Volumn 126, Issue 1 SUPPL. 1, 2004, Pages 347-350

  Marrero, Jorge A ^a   Lok, Anna S F ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; EDITORIAL; FROZEN SECTION; HEPATITIS B; HUMAN; INFECTION RATE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0347991865     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.11.021     Document Type: Editorial

References (28)

1. Conjeevaram HS, Lok AS. Occult Hepatitis B virus infection: a hidden menace? Hepatology 2001;34:204-206.
2. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-276.
3. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-231.
4. Cacciola I, Pollicino T, Squandrito G, Cerenzia G, Villari D, De Franchis R, Santantonio T, Brancatelli S, Colucci G, Raimondo G. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 2000;31:507-512.
5. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001;34:194-203.
6. Matsumoto C, Nishioka K, Oguchi T, Mitsunaga S, Nojiri N, Tadokoro K, Juji T. Detection and quantitation of HBV DNA by semi-nested PCR in donated blood: comparison with HBV serological markers. J Virol Meth 1997;66:61-69.
7. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992;63:107-111.
8. Douglas DD, Taswell H, Rakeia J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993;33:212-216.
9. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific-a-determinant of hepatitis B virus surface antigen and the corresponding fragment of the viral polymerase in chronic virus lacking detectable HbsAg in serum. J Gen Virol 2000;81:1165-1174.
10. Cacciola I, Pollicino T, Squandrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22-26.
11. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S, Watanabe M, Kinoshita Y. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999;58:201-207.
12. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995;23:14-20.
13. Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Want JT, Lee PH, Lai MY, Wang CY, Yang PM. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-1327.
14. Yotsuyanagi H, Shintani Y, Moriya K, Fujie H, Tsutsumi T, Kato T, Nishioka K, Takayama T, Makuuchi M, lino S, Kimura S, Koike K. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000;181:1920-1928.
15. Liang TJ, Baruch Y, Ben-Porath E. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991;13:1044-1051.
16. Brechot C, Jaffredo F, Lagorce D, Gerken G, zum Buschenfelde M, Papakonstontinou A, Hadziyannis S, Romeo R, Colombo M, Rodes J, Bruix J, Williams R, Naoumov N. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998;29:173-183.
17. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in case of occult HBV infection. Gastroenterology 2004;126:102-110.
18. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Alberti A, Fasola M, boffeta P, Nardo G. Case-control study on hepatitis C virus as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC study. Int J Cancer 1999;81:695-699.
19. Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P. Molecular bases for the development of hepatitis B virus-related hepatocellular carcinoma. Sem Cancer Biol 2000;10:211-231.
20. Caldwell SH, Oelsner DH, lezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669.
21. Chung HT, Lai CL, Lok AS. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995;22:25-29.
22. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HbsAg in chronic hepatitis B. Hepatology 1993;18:1313-1318.
23. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HbsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991;13:627-631.
24. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsai SH, Ting LT, Chang FY, Lee SD. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-236.
25. Reherman B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patient's recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-1108.
26. Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K, Omura M, Hikiji K, Kato M. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003;37:1172-1179.
27. Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P, Trelegan CL. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999;29:928-938.
28. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.